Quote Nivolumab
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Read more
€0.00
(tax incl.)
Reference:
HY-P9903
Brand: